7,420
Views
12
CrossRef citations to date
0
Altmetric
Review

Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation

, & ORCID Icon
Article: 2190305 | Received 19 Sep 2022, Accepted 06 Mar 2023, Published online: 13 Apr 2023
 

ABSTRACT

Exclusive breastfeeding is recommended for the first six months of life, but many infants receive pumped milk, formula, donor human milk, or other nutritional sources during this critical period. Substantive evidence shows early nutrition influences development of the microbiome and immune system, affecting lifelong health. However, the underlying mechanisms are unclear and the nuances of human milk feeding are rarely considered. This review synthesizes evidence from human studies and model systems to discuss the impact of different nutritional sources on co-development of the gut microbiome, antigen tolerance, and immunity. We highlight two key mechanisms: epigenetics and the so-called “weaning reaction”. Collectively, this evidence highlights i) the fundamental role of parents’ own milk, fed directly at the breast, as a dynamic and personalized nutrition source that drives developmental programming, and ii) the deficiencies of alternative nutritional sources and priority research areas for improving these alternatives when direct breastfeeding is not possible.

Plain Language Summary

Before they begin eating solid foods, infants may be fed a variety of nutritional sources such as breast milk (“parent’s own milk”, fed directly at the breast or pumped and fed from a bottle), commercial infant formula, or sterilized “donor human milk” from a certified milk bank. Early nutrition affects the infant’s gut microbiome (bacteria living in the intestinal tract), development of their immune system, and their health throughout life. However, it is unclear how different forms of early nutrition affect these important processes. Parent’s own milk contains compounds that support gut microbes and stimulate development of the infant immune system, changing over time to meet infant needs. For many of these compounds, donor human milk contains a lesser amount, and formula contains even less – or none at all. Some compounds are also affected by pumping and storing parents’ own milk. This review highlights how differences among these nutritional sources influence gene expression and gut development to shape the infant microbiome and immune system. Current evidence shows that parent’s own milk, fed at the breast, offers unique benefits that are not replicated by other forms of early nutrition. This review also outlines how early life nutrition research can help us understand human development and develop new ways to provide the best possible start to life for all infants.

Abbreviations

POM=

parent’s own milk

Ig=

immunoglobulin

HMO=

human milk oligosaccharide

NEC=

necrotizing enterocolitis

DPOM=

direct parent’s own milk

EPOM=

expressed parent’s own milk

DHM=

donor human milk

TGF=

transforming growth factor

IL=

interleukin

IGF=

insulin-like growth factor

EGF=

epithelial growth factor

GCSF=

granulocyte colony-stimulating factor

IBD=

inflammatory bowel disease

TNF-α=

tumor necrosis factor alpha

TLR=

toll like receptor

NF-κB=

nuclear factor-κB

RORγt+ Treg=

RAR-related orphan receptor gamma expressing regulatory T cell

FOS=

fructooligosaccharide

GOS=

galactooligosaccharides

FA=

fatty acid

Disclosure statement

M.B.A. receives research funding from the Canadian Institutes of Health Research, US National Institutes of Health, Research Manitoba, the Canada Foundation for Innovation, the Bill and Melinda Gates Foundation, the Manitoba Children’s Hospital Foundation, CIFAR, and the Garfield Weston Foundation. She has previously received funding from Prolacta Biosciences. She has contributed without remuneration to online courses on breast milk and the infant microbiome produced by Microbiome Courses. She serves in a volunteer capacity for the International Society for Research on Human Milk and Lactation and as a member of the US Canada Joint Human Milk Initiative. She has consulted for DSM Nutritional Products and serves on the Scientific Advisory Boards of TinyHealth and MalaikaVx.

Additional information

Funding

This review was supported, in part, by Canadian Institutes of Health Research Canadian Microbiome Initiative 2 Team Grant (MRT-168044) and by the Canada Research Chairs Program. M.B.A. is supported as a Canada Research Chair in the Developmental Origins of Chronic Disease and is a Fellow of the CIFAR Humans & Microbiome Program. S.R.A is supported by a CIHR Canada Graduate Scholarships - Master’s award.